Abstract
Atherosclerosis is characterized by chronic inflammation of the vascular wall. Macrophages, which differentiate from circulating monocytes, give rise to foam cells by excessive accumulation of modified lipoproteins. Atherogenesis subsequently progresses through necrotic core expansion associated with apoptosis and the suppressed clearance of apoptotic macrophage (i.e. efferocytosis), followed by the transition to vulnerable plaques. The vulnerable plaque is characterized by thinning of the fibrous cap and necrotic core expansion. Here, the impact of monocytes/macrophages in both early atherogenesis and advanced plaque progression is discussed with a focus on the potential targeting of inflammatory processes in atherosclerosis.
Keywords: Atherosclerosis, inflammation, vulnerable plaque, chemokines, cytokines, oxidative stress, macrophages, lipoproteins, efferocytosis, fibrous cap
Current Pharmaceutical Design
Title:Novel Strategies to Target Inflammatory Processes in Atherosclerosis
Volume: 19 Issue: 9
Author(s): Toshio Imanishi and Takashi Akasaka
Affiliation:
Keywords: Atherosclerosis, inflammation, vulnerable plaque, chemokines, cytokines, oxidative stress, macrophages, lipoproteins, efferocytosis, fibrous cap
Abstract: Atherosclerosis is characterized by chronic inflammation of the vascular wall. Macrophages, which differentiate from circulating monocytes, give rise to foam cells by excessive accumulation of modified lipoproteins. Atherogenesis subsequently progresses through necrotic core expansion associated with apoptosis and the suppressed clearance of apoptotic macrophage (i.e. efferocytosis), followed by the transition to vulnerable plaques. The vulnerable plaque is characterized by thinning of the fibrous cap and necrotic core expansion. Here, the impact of monocytes/macrophages in both early atherogenesis and advanced plaque progression is discussed with a focus on the potential targeting of inflammatory processes in atherosclerosis.
Export Options
About this article
Cite this article as:
Imanishi Toshio and Akasaka Takashi, Novel Strategies to Target Inflammatory Processes in Atherosclerosis, Current Pharmaceutical Design 2013; 19 (9) . https://dx.doi.org/10.2174/1381612811319090009
DOI https://dx.doi.org/10.2174/1381612811319090009 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Decreased Platelet APP Isoform Ratios in Autosomal Dominant Alzheimer’s Disease: Baseline Data from a DIAN Cohort Subset
Current Alzheimer Research Sympathetic Nervous System in Patients with Sleep Related Breathing Disorders
Current Hypertension Reviews Asymmetric Organocatalytic Tandem/Domino Reactions to Access Bioactive Products
Current Organic Chemistry Imaging in Inflammatory Bowel Disease Mucosal Healing in Ulcerative Colitis: Relevance for Clinical Outcomes
Current Drug Targets Inflammation, Endothelial Dysfunction and Arterial Stiffness as Therapeutic Targets in Cardiovascular Medicine
Current Pharmaceutical Design New Approaches in the Diagnosis of Atherosclerosis and Treatment of Cardiovascular Disease
Recent Patents on Cardiovascular Drug Discovery Engineering Biomimetic Materials for Islet Transplantation
Current Diabetes Reviews Influenza and Stroke Risk: A Key Target Not to be Missed?
Infectious Disorders - Drug Targets Retinal Imaging: A New Tool for Studying Underlying Liability to Cardiovascular Disease in Schizophrenia
Current Psychiatry Reviews Subject Index To Volume 1
Reviews on Recent Clinical Trials Down Regulated Expression of Claudin-1 and Claudin-5 and Up Regulation of β-Catenin: Association with Human Glioma Progression
CNS & Neurological Disorders - Drug Targets Coagulation Disorders in Acute Lung Injury
Current Respiratory Medicine Reviews Autoimmune Neuromuscular Disorders
Current Neuropharmacology The Role of Combined Assessment of Defense Against Oxidative Stress and Inflammation in the Evaluation of Peripheral Arterial Disease
Current Molecular Medicine Synthesis of LDH Nanosheets and their Layer-by-Layer Assembly
Recent Patents on Nanotechnology Pulmonary Arterial Hypertension in HIV-infected Patients
Current Hypertension Reviews Modifying Radiation Damage
Current Drug Targets Patent Selections
Recent Patents on Anti-Infective Drug Discovery Novel Therapeutic Potential of Mitogen-Activated Protein Kinase Activated Protein Kinase 2 (MK2) in Chronic Airway Inflammatory Disorders
Current Drug Targets Editorial (Thematic Issue: Clinical Advances in Immuno-oncology – Progress Towards Selective Cure)
Current Molecular Pharmacology